![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessAuthor Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
-
Article
Open AccessLong-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome
Patients with Wiskott–Aldrich syndrome (WAS) lacking a human leukocyte antigen-matched donor may benefit from gene therapy through the provision of gene-corrected, autologous hematopoietic stem/progenitor cell...
-
Article
Open AccessAutomated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia
Precise classification of acute leukemia (AL) is crucial for adequate treatment. EuroFlow has previously designed an AL orientation tube (ALOT) to guide towards the relevant classification panel (T-cell acute ...
-
Article
TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome
T-cell acute lymphoblastic leukemia (T-ALL) results from leukemic transformation of T-cell precursors arrested at specific differentiation stages, including an ‘early-cortical’ thymic maturation arrest charact...
-
Article
Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia
The tumour suppressor gene PTEN is commonly altered in T-cell acute lymphoblastic leukaemia but its prognostic impact is still debated. We screened a cohort of 573 fully characterised adult and paediatric T-cell ...
-
Article
Open AccessMonitoring molecular response in adult T-cell leukemia by high-throughput sequencing analysis of HTLV-1 clonality
-
Article
Oncogenic PTEN functions and models in T-cell malignancies
PTEN is a protein phosphatase that is crucial to prevent the malignant transformation of T-cells. Although a numerous mechanisms regulate its expression and function, they are often altered in T-cell acute lym...
-
Article
Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL
Constitutively activated FLT3 signaling is common in acute myeloid leukemia, and is currently under evaluation for targeted therapy, whereas little data is available in T-cell acute lymphoblastic leukemia (T-A...